An exploratory analysis of the relationship between cerebral flood flow, mood, and fluid cognition in older adults
Background ASL, a common MRI measure of cerebral blood flow (CBF), is thought to be a potential tool in the detection of preclinical Alzheimer’s disease. This exploratory analysis examined the relationship between CBF, mood, and fluid cognitive performance on the NIH Toolbox Cognition Battery (NIHTB...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2023-12, Vol.19 (S24), p.n/a |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
ASL, a common MRI measure of cerebral blood flow (CBF), is thought to be a potential tool in the detection of preclinical Alzheimer’s disease. This exploratory analysis examined the relationship between CBF, mood, and fluid cognitive performance on the NIH Toolbox Cognition Battery (NIHTB‐CB) as part of an ongoing triglyceride intervention study.
Method
20 female older adults (age 65.6 ± 7.6) underwent ASL MRI when fasting and two hours after a triglyceride intervention. 3D pCASL MRI with background suppression was used to measure CBF in ml/100g/min using label duration = 1.8 s, post‐labeling delay = 2 s, labeling offset = 25‐30 mm, slices = 30, resolution = 2×2×4 mm3, SENSE‐factor = 2, TR/TE = 5000/18 ms. We also performed a reference scan (M0, 1 minute) identical to the one above but with no labeling or background suppression and TR = 10,000 ms. CBF was measured globally and in four regions of interest: angular gyrus (AG), posterior cingulate (PC), temporal lobe, and the hippocampus. Subjects completed the Generalized Anxiety Disorder Scale (GAD‐7) and MoCA at screening. The NIHTB‐CB was completed following the second MRI, and age‐adjusted scores were used in all analyses.
Result
Baseline global CBF, AG CBF, and hippocampal CBF negatively correlated with GAD‐7 scores (r = ‐.797, p |
---|---|
ISSN: | 1552-5260 1552-5279 |
DOI: | 10.1002/alz.083157 |